These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30105399)

  • 21. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ayahuasca - religion, life-style or drug?].
    Neu P
    Fortschr Neurol Psychiatr; 2020 Oct; 88(10):669-673. PubMed ID: 32544955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination.
    Jiménez-Garrido DF; Gómez-Sousa M; Ona G; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
    Sci Rep; 2020 Mar; 10(1):4075. PubMed ID: 32139811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
    Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
    Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of ayahuasca use in North America.
    Harris R; Gurel L
    J Psychoactive Drugs; 2012; 44(3):209-15. PubMed ID: 23061320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach.
    Franquesa A; Sainz-Cort A; Gandy S; Soler J; Alcázar-Córcoles MÁ; Bouso JC
    Psychiatry Res; 2018 Jun; 264():334-339. PubMed ID: 29674223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ayahuasca's Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness.
    Mian MN; Altman BR; Earleywine M
    J Psychoactive Drugs; 2020; 52(2):130-137. PubMed ID: 31570056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ayahuasca and the traveller: A scoping review of risks and possible benefits.
    Houle SKD; Evans D; Carter CA; Schlagenhauf P
    Travel Med Infect Dis; 2021; 44():102206. PubMed ID: 34785376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions.
    Liester MB; Prickett JI
    J Psychoactive Drugs; 2012; 44(3):200-8. PubMed ID: 23061319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ayahuasca ceremony leaders' perspectives on special considerations for eating disorders.
    Williams M; Kingston Miller A; Lafrance A
    Eat Disord; 2024; 32(2):120-139. PubMed ID: 37943076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study.
    Bouso JC; González D; Fondevila S; Cutchet M; Fernández X; Ribeiro Barbosa PC; Alcázar-Córcoles MÁ; Araújo WS; Barbanoj MJ; Fábregas JM; Riba J
    PLoS One; 2012; 7(8):e42421. PubMed ID: 22905130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
    Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.
    dos Santos RG
    J Psychoactive Drugs; 2013; 45(1):68-78. PubMed ID: 23662333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of ayahuasca administered in two repeated doses.
    Dos Santos RG; Grasa E; Valle M; Ballester MR; Bouso JC; Nomdedéu JF; Homs R; Barbanoj MJ; Riba J
    Psychopharmacology (Berl); 2012 Feb; 219(4):1039-53. PubMed ID: 21842159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examining changes in personality following shamanic ceremonial use of ayahuasca.
    Weiss B; Miller JD; Carter NT; Keith Campbell W
    Sci Rep; 2021 Mar; 11(1):6653. PubMed ID: 33758236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca.
    Apud Peláez IE
    J Psychoactive Drugs; 2020; 52(3):264-272. PubMed ID: 32362241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
    Heise CW; Brooks DE
    J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study.
    Perkins D; Pagni BA; Sarris J; Barbosa PCR; Chenhall R
    Front Pharmacol; 2022; 13():884703. PubMed ID: 36386199
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychological and neuropsychological assessment of regular hoasca users.
    Barbosa PC; Strassman RJ; da Silveira DX; Areco K; Hoy R; Pommy J; Thoma R; Bogenschutz M
    Compr Psychiatry; 2016 Nov; 71():95-105. PubMed ID: 27653781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
    McKenna DJ
    Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.